Skip to main content
Dabur India Ltd. logo

Dabur India Ltd. — Investor Relations & Filings

Ticker · DABUR ISIN · INE016A01026 LEI · 335800MJPUA2E1FSFL38 BSE.NS Manufacturing
Open in API
Filings indexed 2,042 across all filing types
Latest filing 2025-12-05 Regulatory Filings
Country IN India
Listing BSE.NS DABUR

About Dabur India Ltd.

https://www.dabur.com

Dabur India Ltd. specializes in Ayurvedic and natural healthcare solutions, managing a diverse portfolio across health supplements, oral care, hair care, skin care, home care, and food and beverages. Established in 1884, the organization integrates traditional Ayurvedic wisdom with modern scientific research to develop standardized herbal products. Key brands include Dabur Chyawanprash, Dabur Honey, Real fruit juices, Vatika, and Dabur Red Paste. The company maintains a robust research and development framework to support its focus on natural ingredients and holistic health. Its operations serve a wide demographic across international markets, emphasizing the synergy between nature and science through an extensive distribution network and a commitment to quality-driven consumer products.

Recent filings

Filing Released Lang Actions
Receipt of Observation Letter with "no objection" from the NSE in relation to the Scheme of Amalgamation of Sesa Care Private Limited with and into Dabur India Limited and their respective ....
Regulatory Filings Classification · 100% confidence The document is an observation letter from the National Stock Exchange of India (NSE) addressed to Dabur India Limited regarding a draft Scheme of Amalgamation between Sesa Care Private Limited and Dabur India Limited. It references regulatory provisions under the Companies Act, 2013, SEBI Master Circulars, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The letter provides detailed comments and conditions that the company must comply with before filing the scheme with the National Company Law Tribunal (NCLT). It explicitly states it is an observation letter and a 'No objection' letter to enable filing the draft scheme with NCLT, not the scheme itself or a report. The document is regulatory in nature, providing compliance observations and instructions rather than financial data or report content. It is not a financial report, earnings release, or management discussion but a regulatory communication from the stock exchange. Therefore, it fits best under Regulatory Filings (RNS).
2025-12-05 English
Amalgamation/Merger
Regulatory Filings Classification · 95% confidence The document is an observation letter from the National Stock Exchange of India (NSE) addressed to Dabur India Limited regarding a draft Scheme of Amalgamation between Sesa Care Private Limited and Dabur India Limited. It references SEBI regulations and provides detailed comments and conditions that the company must comply with before filing the scheme with the National Company Law Tribunal (NCLT). The letter is regulatory in nature, providing comments and no-objection status but does not contain financial statements or detailed financial analysis itself. It is not a full report like an Annual Report or Interim Report, nor is it a shareholder meeting material or voting result. It is a regulatory communication related to a merger scheme, but it is not the merger filing itself or a merger proxy statement. Given the nature of the document as a regulatory observation letter and compliance communication, it fits best under Regulatory Filings (RNS). The document length is substantial and contains detailed regulatory instructions, supporting a high confidence in classification.
2025-12-05 English
Amalgamation/Merger
Regulatory Filings
2025-12-05 English
Please find attached Observation Letter with ''no adverse observations'' received from BSE Limited in relation to the Scheme of Amalgamation of Sesa Care Private Limited with and into Dabur ....
Regulatory Filings
2025-12-05 English
Credit Rating
Regulatory Filings Classification · 95% confidence The document is very short (750 characters) and contains no substantive text or financial data. It mainly includes digital signatures and omitted images, with no indication of financial results, management changes, or other report content. There is no mention of any report title, fiscal period, or regulatory form. Given the brevity and nature of the content, it appears to be a certification or attestation document rather than a full report or announcement. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2025-11-20 English
Re-affirmation of Credit Ratings by CRISIL Ratings Limited
Regulatory Filings Classification · 95% confidence The document is very short (750 characters) and contains no substantive financial data or detailed report content. It includes digital signatures and some omitted images but no text indicating financial results, management discussion, or regulatory disclosures. There is no mention of any report title, fiscal period, or regulatory body. Given the brevity and nature of the content, it is likely a certification or a short announcement rather than a full report. According to the rules, such short documents that do not contain actual financial data or detailed report content should be classified as Regulatory Filings (RNS).
2025-11-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.